Therapy News and Research

RSS

World's first nanofluidic device with complex 3-D surfaces

Researchers at the Commerce Department's National Institute of Standards and Technology (NIST) and Cornell University have capitalized on a process for manufacturing integrated circuits at the nanometer (billionth of a meter) level and used it to develop a method for engineering the first-ever nanoscale fluidic (nanofluidic) device with complex three-dimensional surfaces.

1 Apr 2009

Novel assays provide new insight into why patients are in heart failure

A failing heart makes a lot of a hormone needed to eliminate the excess salt and water bloating the body but not enough of the enzyme needed to activate it, researchers say.

1 Apr 2009

Eye exercises help patients work out vision problems

You've probably been there. In a doctor's office, being advised to do what you dread - exercise.

1 Apr 2009

Researchers develop mouse models of leukemia that predict response to chemotherapy

Being able to accurately predict how a given cancer will respond to chemotherapy would spare patients with non-responsive tumors the burden of undergoing toxic and ultimately unhelpful treatment.

1 Apr 2009

Researchers examine medical effects of bed bugs and control and eradication strategies

A review of previously published articles indicates there is little evidence supporting an effective treatment of bites from bed bugs, that these insects do not appear to transmit disease, and control and eradication of bed bugs is challenging, according to an article in the April 1 issue of JAMA .

1 Apr 2009

California stimulus funding not enough to stave off cuts to some health care services

California Gov. Arnold Schwarzenegger (R) on Friday signed five bills into law that allow California to receive more than $17.5 billion in federal economic stimulus aid, but the funding will not be enough for the state to avoid $3 billion in tax increases and cuts to services to balance its budget, the San Francisco Chronicle reports.

31 Mar 2009

ImQuest presents data on the anti-hepatitis B virus activity of Pyrimidinediones

ImQuest Life Sciences today presented important new results on the continued development of the pyrimidinedione small molecules as antiviral agents at the 13th International Symposium on Viral Hepatitis and Liver Disease meeting held last week in Washington D.C.

31 Mar 2009

Quantum Immunologics announces the filing of two important provisional patent applications

Quantum Immunologics, Inc. (QI), a Florida-based company specializing in cancer immunotherapy, has recently filed two provisional patent applications relating to their work in cancer immunotherapy.

31 Mar 2009

Blood test that predicts seriousness of a head injury gains momentum

A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.

31 Mar 2009

Ultrasound saves money, improves rheumatologic care

A few years back, 76-year-old Joseph Buggie woke up to pain so throbbing, he couldn't muster the strength to roll over, let alone crawl out of bed.

31 Mar 2009

Basilea Pharmaceutica expands potential commercial availability of Toctino in Europe

Basilea Pharmaceutica Ltd. has announced the submission of a Marketing Authorization Application (MAA) for Toctino (alitretinoin) in 13 additional European Union (EU) Member States as well as in Norway and Iceland. Toctino is a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids.

31 Mar 2009

The clinical availability of CT colonography

Computed tomographic (CT) colonography allows the visualization of extracolonic organs, thereby permitting the detection of potentially significant pathologies beyond the colon.

30 Mar 2009

SARcode announces results of phase 1 trial of SAR 1118 ophthalmic solution in healthy adult subjects

SARcode Corporation announced today the results of its Phase 1 randomized, double-masked, placebo-controlled trial of the safety, tolerability, and pharmacokinetics of single- and multiple-escalating doses of SAR 1118 Ophthalmic Solution in healthy volunteers.

30 Mar 2009

New radiation-free targeted therapy detects and eliminates breast cancer tumors in mice

Combining a compound known as a gallium corrole with a protein carrier results in a targeted cancer therapy that is able to detect and eliminate tumors in mice with seemingly fewer side effects than other breast-cancer treatments, says a team of researchers from the California Institute of Technology (Caltech), the Israel Institute of Technology (Technion) and the Cedars-Sinai Medical Center.

30 Mar 2009

Mutations within a conservative region of hepatitis C virus affect therapy

At least 200 million individuals are currently infected with hepatitis C virus (HCV) worldwide.

30 Mar 2009

Improving cancer therapy achieved through taste, odor intervention

Cancer and its therapies, including chemotherapy and radiotherapy, may directly alter and damage taste and odor perception, possibly leading to patient malnutrition, and in severe cases, significant morbidity, according to a Virginia Tech - Wake Forest University Comprehensive Cancer Center compilation of various existing studies.

30 Mar 2009

Therapy News and Research

World's first nanofluidic device with complex 3-D surfaces

Novel assays provide new insight into why patients are in heart failure

Eye exercises help patients work out vision problems

Researchers develop mouse models of leukemia that predict response to chemotherapy

Researchers examine medical effects of bed bugs and control and eradication strategies

California stimulus funding not enough to stave off cuts to some health care services

ImQuest presents data on the anti-hepatitis B virus activity of Pyrimidinediones

Quantum Immunologics announces the filing of two important provisional patent applications

Blood test that predicts seriousness of a head injury gains momentum

Ultrasound saves money, improves rheumatologic care

Basilea Pharmaceutica expands potential commercial availability of Toctino in Europe

The clinical availability of CT colonography

SARcode announces results of phase 1 trial of SAR 1118 ophthalmic solution in healthy adult subjects

New radiation-free targeted therapy detects and eliminates breast cancer tumors in mice

Mutations within a conservative region of hepatitis C virus affect therapy

Improving cancer therapy achieved through taste, odor intervention

Eye cells believed to be retinal stem cells are misidentified

New cancer genomics web-based tools provide researchers a powerful new to visualize and analyze data

Potential therapeutic strategy for fulminant hepatic failure

New molecular marker of gastric cancer

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News